Saba Capital Management’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-270,751
| Closed | -$2.71M | – | 979 |
|
|
2022
Q3 | $2.71M | Hold |
270,751
| – | – | 0.03% | 576 |
|
|
2022
Q2 | $2.68M | Hold |
270,751
| – | – | 0.03% | 607 |
|
|
2022
Q1 | $2.67M | Buy |
270,751
+214,300
| +380% | +$2.11M | 0.04% | 537 |
|
|
2021
Q4 | $551K | Buy |
56,451
+29,577
| +110% | +$289K | 0.01% | 612 |
|
|
2021
Q3 | $263K | Buy |
+26,874
| New | +$263K | 0.01% | 473 |
|